Kathryn E. Wengel - 08 Feb 2024 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief TO and Risk Officer
Signature
/s/ Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Issuer symbol
JNJ
Transactions as of
08 Feb 2024
Net transactions value
-$157,737
Form type
4
Filing time
12 Feb 2024, 19:25:14 UTC
Previous filing
08 Feb 2024
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1,971 +3% $0.000000 67,905 08 Feb 2024 Direct F1
transaction JNJ Common Stock Tax liability $157,737 -1,009 -1.5% $156.33 66,896 08 Feb 2024 Direct F2
holding JNJ Common Stock 64 08 Feb 2024 By 401k F3
holding JNJ Common Stock 281 08 Feb 2024 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1,971 -100% $0.000000* 0 08 Feb 2024 Common Stock 1,971 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Long-Term Incentive Plan on February 8, 2021 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2024).